多发性硬化症 (MS) 疾病修饰疗法 (DMT) 的知识映射:一个参考资料分析
Fan Jiang1,2,3, Fenghe Zhang4, Yue Su1
1Department of Neurology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Heliyon
|June 13, 2024
概括
这项研究分析了多发性硬化症疾病修饰疗法 (DMT),综合了新兴,传统和交叉治疗的文献. 未来的研究应该专注于组合试验和针对多发性硬化症患者的个性化药物.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性硬化症 (MS) 是一种复杂的自身免疫性疾病,研究领域正在迅速扩大.
- 综合和组织关于MS疾病修饰疗法 (DMT) 的大量文献至关重要.
研究的目的:
- 对MS的新兴,传统和跨领域的DMT进行文献计量分析.
- 确定当前的研究趋势和MS治疗的未来方向.
主要方法:
- 从Web of Science核心收藏中对4142 (e-DMT),6521 (t-DMT) 和1793 (I-DMT) 出版物的图书法分析.
- 数据使用VOSviewer,Citespace,R包"Bibliometrix"和Scimago Graphica.com进行分析.
- 利用最大概率 (LLR) 聚类和爆发引用算法.
主要成果:
- 确定了关键的研究主题,包括COVID-19 mRNA疫苗安全性,治疗惯性,克拉迪宾片,自身造血干细胞移植 (aHSCT),渐进性MS和儿科MS.
- 对国家,机构,作者,关键词和参考进行了描述和预测分析.
结论:
- 未来的MS DMT研究应该优先考虑组合试验和交叉试验,以制定个性化的治疗计划.
- 关键领域包括单克隆抗体,克拉迪宾,aHSCT,mRNA COVID-19疫苗的影响,治疗惯性,患者坚持和生物标志物发现.
相关概念视频
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...


